 | • レポートコード：MRC2-11QY12202 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はHIV治療薬のグローバル市場について調査・分析したレポートです。種類別（ヌクレオシドアナログ逆転写酵素阻害剤（NRTI）、非ヌクレオシド逆転写酵素阻害剤（NNRTI）、侵入・融合阻害剤、プロテアーゼ阻害剤（PI）、インテグラーゼ阻害剤、共受容体拮抗薬）市場規模、用途別（病院、クリニック、ラボ）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別HIV治療薬の競争状況、市場シェア ・世界のHIV治療薬市場：種類別市場規模 2015年-2020年（ヌクレオシドアナログ逆転写酵素阻害剤（NRTI）、非ヌクレオシド逆転写酵素阻害剤（NNRTI）、侵入・融合阻害剤、プロテアーゼ阻害剤（PI）、インテグラーゼ阻害剤、共受容体拮抗薬） ・世界のHIV治療薬市場：種類別市場規模予測 2021年-2026年（ヌクレオシドアナログ逆転写酵素阻害剤（NRTI）、非ヌクレオシド逆転写酵素阻害剤（NNRTI）、侵入・融合阻害剤、プロテアーゼ阻害剤（PI）、インテグラーゼ阻害剤、共受容体拮抗薬） ・世界のHIV治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック、ラボ） ・世界のHIV治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック、ラボ） ・北米のHIV治療薬市場分析：米国、カナダ ・ヨーロッパのHIV治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのHIV治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のHIV治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのHIV治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Boehringer Ingelheim International GmbH、Merck & Co.、ViiV Healthcare、AbbVie、F. Hoffmann-La Roche Ltd.、Teva Pharmaceutical Industries Ltd.、Bristol-Myers Squibb、Gilead Sciences、Johnson & Johnson、Cipla Limited ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease.
HIV spreads through fluidic exchange with some infected person such as blood transfer or sharing needles with someone who is HIV infected. In addition, HIV can spread from infected mother to child during pregnancy. Some of the symptoms of HIV infection are slight fever, fatigue, swollen glands, headaches and muscle aches.
Market Analysis and Insights: Global HIV Therapeutics Market
The global HIV Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global HIV Therapeutics Scope and Market Size
HIV Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global HIV Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Boehringer Ingelheim International GmbH
Merck & Co.
ViiV Healthcare
AbbVie
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Bristol-Myers Squibb
Gilead Sciences
Johnson & Johnson
Cipla Limited
Market segment by Type, the product can be split into
Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Entry and Fusion Inhibitors
Protease Inhibitors (PIs)
Integrase Inhibitors
Coreceptor Antagonists
Market segment by Application, split into
Hospitals
Clinics
Labs
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by HIV Therapeutics Revenue
1.4 Market by Type
1.4.1 Global HIV Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
1.4.3 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.4.4 Entry and Fusion Inhibitors
1.4.5 Protease Inhibitors (PIs)
1.4.6 Integrase Inhibitors
1.4.7 Coreceptor Antagonists
1.5 Market by Application
1.5.1 Global HIV Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Labs
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global HIV Therapeutics Market Perspective (2015-2026)
2.2 Global HIV Therapeutics Growth Trends by Regions
2.2.1 HIV Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 HIV Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 HIV Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 HIV Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key HIV Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top HIV Therapeutics Players by Market Size
3.1.1 Global Top HIV Therapeutics Players by Revenue (2015-2020)
3.1.2 Global HIV Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global HIV Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global HIV Therapeutics Market Concentration Ratio
3.2.1 Global HIV Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by HIV Therapeutics Revenue in 2019
3.3 HIV Therapeutics Key Players Head office and Area Served
3.4 Key Players HIV Therapeutics Product Solution and Service
3.5 Date of Enter into HIV Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global HIV Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global HIV Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global HIV Therapeutics Market Size by Application (2015-2020)
5.2 Global HIV Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America HIV Therapeutics Market Size (2015-2020)
6.2 HIV Therapeutics Key Players in North America (2019-2020)
6.3 North America HIV Therapeutics Market Size by Type (2015-2020)
6.4 North America HIV Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe HIV Therapeutics Market Size (2015-2020)
7.2 HIV Therapeutics Key Players in Europe (2019-2020)
7.3 Europe HIV Therapeutics Market Size by Type (2015-2020)
7.4 Europe HIV Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China HIV Therapeutics Market Size (2015-2020)
8.2 HIV Therapeutics Key Players in China (2019-2020)
8.3 China HIV Therapeutics Market Size by Type (2015-2020)
8.4 China HIV Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan HIV Therapeutics Market Size (2015-2020)
9.2 HIV Therapeutics Key Players in Japan (2019-2020)
9.3 Japan HIV Therapeutics Market Size by Type (2015-2020)
9.4 Japan HIV Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia HIV Therapeutics Market Size (2015-2020)
10.2 HIV Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia HIV Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia HIV Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India HIV Therapeutics Market Size (2015-2020)
11.2 HIV Therapeutics Key Players in India (2019-2020)
11.3 India HIV Therapeutics Market Size by Type (2015-2020)
11.4 India HIV Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America HIV Therapeutics Market Size (2015-2020)
12.2 HIV Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America HIV Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America HIV Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Boehringer Ingelheim International GmbH
13.1.1 Boehringer Ingelheim International GmbH Company Details
13.1.2 Boehringer Ingelheim International GmbH Business Overview
13.1.3 Boehringer Ingelheim International GmbH HIV Therapeutics Introduction
13.1.4 Boehringer Ingelheim International GmbH Revenue in HIV Therapeutics Business (2015-2020))
13.1.5 Boehringer Ingelheim International GmbH Recent Development
13.2 Merck & Co.
13.2.1 Merck & Co. Company Details
13.2.2 Merck & Co. Business Overview
13.2.3 Merck & Co. HIV Therapeutics Introduction
13.2.4 Merck & Co. Revenue in HIV Therapeutics Business (2015-2020)
13.2.5 Merck & Co. Recent Development
13.3 ViiV Healthcare
13.3.1 ViiV Healthcare Company Details
13.3.2 ViiV Healthcare Business Overview
13.3.3 ViiV Healthcare HIV Therapeutics Introduction
13.3.4 ViiV Healthcare Revenue in HIV Therapeutics Business (2015-2020)
13.3.5 ViiV Healthcare Recent Development
13.4 AbbVie
13.4.1 AbbVie Company Details
13.4.2 AbbVie Business Overview
13.4.3 AbbVie HIV Therapeutics Introduction
13.4.4 AbbVie Revenue in HIV Therapeutics Business (2015-2020)
13.4.5 AbbVie Recent Development
13.5 F. Hoffmann-La Roche Ltd.
13.5.1 F. Hoffmann-La Roche Ltd. Company Details
13.5.2 F. Hoffmann-La Roche Ltd. Business Overview
13.5.3 F. Hoffmann-La Roche Ltd. HIV Therapeutics Introduction
13.5.4 F. Hoffmann-La Roche Ltd. Revenue in HIV Therapeutics Business (2015-2020)
13.5.5 F. Hoffmann-La Roche Ltd. Recent Development
13.6 Teva Pharmaceutical Industries Ltd.
13.6.1 Teva Pharmaceutical Industries Ltd. Company Details
13.6.2 Teva Pharmaceutical Industries Ltd. Business Overview
13.6.3 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Introduction
13.6.4 Teva Pharmaceutical Industries Ltd. Revenue in HIV Therapeutics Business (2015-2020)
13.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
13.7 Bristol-Myers Squibb
13.7.1 Bristol-Myers Squibb Company Details
13.7.2 Bristol-Myers Squibb Business Overview
13.7.3 Bristol-Myers Squibb HIV Therapeutics Introduction
13.7.4 Bristol-Myers Squibb Revenue in HIV Therapeutics Business (2015-2020)
13.7.5 Bristol-Myers Squibb Recent Development
13.8 Gilead Sciences
13.8.1 Gilead Sciences Company Details
13.8.2 Gilead Sciences Business Overview
13.8.3 Gilead Sciences HIV Therapeutics Introduction
13.8.4 Gilead Sciences Revenue in HIV Therapeutics Business (2015-2020)
13.8.5 Gilead Sciences Recent Development
13.9 Johnson & Johnson
13.9.1 Johnson & Johnson Company Details
13.9.2 Johnson & Johnson Business Overview
13.9.3 Johnson & Johnson HIV Therapeutics Introduction
13.9.4 Johnson & Johnson Revenue in HIV Therapeutics Business (2015-2020)
13.9.5 Johnson & Johnson Recent Development
13.10 Cipla Limited
13.10.1 Cipla Limited Company Details
13.10.2 Cipla Limited Business Overview
13.10.3 Cipla Limited HIV Therapeutics Introduction
13.10.4 Cipla Limited Revenue in HIV Therapeutics Business (2015-2020)
13.10.5 Cipla Limited Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. HIV Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by HIV Therapeutics Revenue
Table 3. Ranking of Global Top HIV Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global HIV Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Table 6. Key Players of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Table 7. Key Players of Entry and Fusion Inhibitors
Table 8. Key Players of Protease Inhibitors (PIs)
Table 9. Key Players of Integrase Inhibitors
Table 10. Key Players of Coreceptor Antagonists
Table 11. Global HIV Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global HIV Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global HIV Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global HIV Therapeutics Market Share by Regions (2015-2020)
Table 15. Global HIV Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global HIV Therapeutics Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. HIV Therapeutics Market Growth Strategy
Table 21. Main Points Interviewed from Key HIV Therapeutics Players
Table 22. Global HIV Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 23. Global HIV Therapeutics Market Share by Players (2015-2020)
Table 24. Global Top HIV Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Therapeutics as of 2019)
Table 25. Global HIV Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players HIV Therapeutics Product Solution and Service
Table 28. Date of Enter into HIV Therapeutics Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global HIV Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 31. Global HIV Therapeutics Market Size Share by Type (2015-2020)
Table 32. Global HIV Therapeutics Revenue Market Share by Type (2021-2026)
Table 33. Global HIV Therapeutics Market Size Share by Application (2015-2020)
Table 34. Global HIV Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 35. Global HIV Therapeutics Market Size Share by Application (2021-2026)
Table 36. North America Key Players HIV Therapeutics Revenue (2019-2020) (Million US$)
Table 37. North America Key Players HIV Therapeutics Market Share (2019-2020)
Table 38. North America HIV Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 39. North America HIV Therapeutics Market Share by Type (2015-2020)
Table 40. North America HIV Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 41. North America HIV Therapeutics Market Share by Application (2015-2020)
Table 42. Europe Key Players HIV Therapeutics Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players HIV Therapeutics Market Share (2019-2020)
Table 44. Europe HIV Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 45. Europe HIV Therapeutics Market Share by Type (2015-2020)
Table 46. Europe HIV Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 47. Europe HIV Therapeutics Market Share by Application (2015-2020)
Table 48. China Key Players HIV Therapeutics Revenue (2019-2020) (Million US$)
Table 49. China Key Players HIV Therapeutics Market Share (2019-2020)
Table 50. China HIV Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 51. China HIV Therapeutics Market Share by Type (2015-2020)
Table 52. China HIV Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 53. China HIV Therapeutics Market Share by Application (2015-2020)
Table 54. Japan Key Players HIV Therapeutics Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players HIV Therapeutics Market Share (2019-2020)
Table 56. Japan HIV Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 57. Japan HIV Therapeutics Market Share by Type (2015-2020)
Table 58. Japan HIV Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 59. Japan HIV Therapeutics Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players HIV Therapeutics Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players HIV Therapeutics Market Share (2019-2020)
Table 62. Southeast Asia HIV Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia HIV Therapeutics Market Share by Type (2015-2020)
Table 64. Southeast Asia HIV Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia HIV Therapeutics Market Share by Application (2015-2020)
Table 66. India Key Players HIV Therapeutics Revenue (2019-2020) (Million US$)
Table 67. India Key Players HIV Therapeutics Market Share (2019-2020)
Table 68. India HIV Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 69. India HIV Therapeutics Market Share by Type (2015-2020)
Table 70. India HIV Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 71. India HIV Therapeutics Market Share by Application (2015-2020)
Table 72. Central & South America Key Players HIV Therapeutics Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players HIV Therapeutics Market Share (2019-2020)
Table 74. Central & South America HIV Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America HIV Therapeutics Market Share by Type (2015-2020)
Table 76. Central & South America HIV Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America HIV Therapeutics Market Share by Application (2015-2020)
Table 78. Boehringer Ingelheim International GmbH Company Details
Table 79. Boehringer Ingelheim International GmbH Business Overview
Table 80. Boehringer Ingelheim International GmbH Product
Table 81. Boehringer Ingelheim International GmbH Revenue in HIV Therapeutics Business (2015-2020) (Million US$)
Table 82. Boehringer Ingelheim International GmbH Recent Development
Table 83. Merck & Co. Company Details
Table 84. Merck & Co. Business Overview
Table 85. Merck & Co. Product
Table 86. Merck & Co. Revenue in HIV Therapeutics Business (2015-2020) (Million US$)
Table 87. Merck & Co. Recent Development
Table 88. ViiV Healthcare Company Details
Table 89. ViiV Healthcare Business Overview
Table 90. ViiV Healthcare Product
Table 91. ViiV Healthcare Revenue in HIV Therapeutics Business (2015-2020) (Million US$)
Table 92. ViiV Healthcare Recent Development
Table 93. AbbVie Company Details
Table 94. AbbVie Business Overview
Table 95. AbbVie Product
Table 96. AbbVie Revenue in HIV Therapeutics Business (2015-2020) (Million US$)
Table 97. AbbVie Recent Development
Table 98. F. Hoffmann-La Roche Ltd. Company Details
Table 99. F. Hoffmann-La Roche Ltd. Business Overview
Table 100. F. Hoffmann-La Roche Ltd. Product
Table 101. F. Hoffmann-La Roche Ltd. Revenue in HIV Therapeutics Business (2015-2020) (Million US$)
Table 102. F. Hoffmann-La Roche Ltd. Recent Development
Table 103. Teva Pharmaceutical Industries Ltd. Company Details
Table 104. Teva Pharmaceutical Industries Ltd. Business Overview
Table 105. Teva Pharmaceutical Industries Ltd. Product
Table 106. Teva Pharmaceutical Industries Ltd. Revenue in HIV Therapeutics Business (2015-2020) (Million US$)
Table 107. Teva Pharmaceutical Industries Ltd. Recent Development
Table 108. Bristol-Myers Squibb Company Details
Table 109. Bristol-Myers Squibb Business Overview
Table 110. Bristol-Myers Squibb Product
Table 111. Bristol-Myers Squibb Revenue in HIV Therapeutics Business (2015-2020) (Million US$)
Table 112. Bristol-Myers Squibb Recent Development
Table 113. Gilead Sciences Business Overview
Table 114. Gilead Sciences Product
Table 115. Gilead Sciences Company Details
Table 116. Gilead Sciences Revenue in HIV Therapeutics Business (2015-2020) (Million US$)
Table 117. Gilead Sciences Recent Development
Table 118. Johnson & Johnson Company Details
Table 119. Johnson & Johnson Business Overview
Table 120. Johnson & Johnson Product
Table 121. Johnson & Johnson Revenue in HIV Therapeutics Business (2015-2020) (Million US$)
Table 122. Johnson & Johnson Recent Development
Table 123. Cipla Limited Company Details
Table 124. Cipla Limited Business Overview
Table 125. Cipla Limited Product
Table 126. Cipla Limited Revenue in HIV Therapeutics Business (2015-2020) (Million US$)
Table 127. Cipla Limited Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HIV Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Features
Figure 3. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features
Figure 4. Entry and Fusion Inhibitors Features
Figure 5. Protease Inhibitors (PIs) Features
Figure 6. Integrase Inhibitors Features
Figure 7. Coreceptor Antagonists Features
Figure 8. Global HIV Therapeutics Market Share by Application: 2020 VS 2026
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Labs Case Studies
Figure 12. HIV Therapeutics Report Years Considered
Figure 13. Global HIV Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global HIV Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global HIV Therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global HIV Therapeutics Market Share by Players in 2019
Figure 18. Global Top HIV Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by HIV Therapeutics Revenue in 2019
Figure 20. North America HIV Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe HIV Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China HIV Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan HIV Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia HIV Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India HIV Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America HIV Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
ヒト免疫不全ウイルス（HIV）-1治療薬の世界市場（～2026年） The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS).AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and can…- テロメラーゼ逆転写酵素の世界市場（～2026年） Market Analysis and Insights: Global Telomerase Reverse Transcriptase Market The global Telomerase Reverse Transcriptase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Telomerase Reverse Transcriptase Scope and Market…
- HIV薬の世界市場（～2026年） HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population. One…
- TNF阻害剤の世界市場（～2026年） TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflamm…
- プロテアソーム阻害剤の世界市場（～2026年） Proteasome inhibitors are drugs that block the action of proteasomes, cellular complexes that break down proteins. Proteasome inhibitors are being studied in the treatment of cancer and are used in treating multiple myeloma. Market Analysis and Insights: Global Proteasome Inhibitors Market The globa…